Search

everythinglearnresearchcommunity

for

Search:↓

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.

Trichomycosis axillaris is a treatable bacterial infection of underarm hair.

Synthetic hormone treatment reduces melanin and hair growth in rats.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Chemotherapy can cause significant but usually reversible hair loss, and managing it involves patient education and hair care strategies.

A new nanoagent effectively kills bacteria and speeds up wound healing.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

A new method creates valuable compounds for drug discovery by breaking traditional chemical rules.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Curcumin spanlastics are the most effective for cancer therapy due to their strong antimicrobial, antioxidant, and antitumor effects.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Both treatments are safe and effective, but anthralin may work better for some patients.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Topical treatments and lasers can improve axillary hyperpigmentation, but no best method is established yet.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Avoiding dyed wigs and clothing improved severe allergic reactions in a woman treated with diphencyprone.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

A new treatment for hair loss shows promise with fewer side effects.

Phenylephrine may help prevent hair loss from pulling on the hair roots.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Leflunomide and anthralin may effectively treat severe alopecia areata.